Magnesium, sodium, and potassium content and [3H]ouabain binding capacity of skeletal muscle in relatives of patients with type 2 diabetes: Effect of dexamethasone

Metabolism: Clinical and Experimental

Volumn 51, Issue 10, 2002, Pages 1331-1339

  Djurhuus, M S ^a,b   Henriksen, J E ^a,b   Klitgaard, N A H ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MAGNESIUM; OUABAIN; POTASSIUM; SODIUM; TRITIUM; WATER;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIET RESTRICTION; DISEASE PREDISPOSITION; DRUG EFFECT; ELECTROLYTE BALANCE; ELECTROLYTE DISTURBANCE; ELECTROLYTE METABOLISM; FEMALE; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; ISOTOPE LABELING; MAGNESIUM BLOOD LEVEL; MALE; MUSCLE BIOPSY; MUSCLE LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BINDING; QUADRICEPS FEMORIS MUSCLE; RELATIVE; SKELETAL MUSCLE; STATISTICAL ANALYSIS; VASTUS LATERALIS MUSCLE;

EID: 0036796592     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.35199     Document Type: Article

References (58)

1. Sjøgren A, Florén CH, Nilsson Å: Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 35:459-463, 1986
2. Sjøgren A, Florén CH, Nilsson Å: Oral administration of magnesium hydroxide to subjects with insulin-dependent diabetes mellitus: Effects on magnesium and potassium levels and on insulin requirements. Magnesium 7:117-122, 1988
3. Johansson G, Danielson BG, Ljunghall S, et al: Evidence for a disturbed magnesium metabolism in diabetes mellitus. Magnes Bull 2:178-180, 1981
4. Sjøgren A, Florén CH, Nilsson Å: Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 224:461-466, 1988
5. Paolisso G, Barbagallo M: Hypertension, diabetes mellitus, and insulin resistance. The role of intracellular magnesium. Am J Hypertens 10:346-355, 1997
6. Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 136:480-490, 1998
7. Rasmussen HS, McNair P, Göransson L, et al: Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med 148:329-332, 1988
8. Rasmussen HS, Aurup P, Goldstein K, et al: Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 149:1050-1053, 1989
9. Singh RB: Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death. Magnes Trace Elem 9:143-151, 1990
10. Ma J, Folsom AR, Melnick SL, et al: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 48:927-940, 1995
11. Davis WH, Leary WP, Reyes AJ, et al: Monotherapy with magnesium increases abnormally low high density lipoprotein cholesterol: A clinical assay. Curr Ther Res 36:341-346, 1984
12. Kisters K, Spieker C, Tepel M, et al: New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 6:355-360, 1993
13. Kirsten R, Heintz B, Nelson K, et al: Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency. Eur J Clin Pharmacol 34:133-137, 1988
14. Djurhuus MS, Henriksen JE, Klitgaard NAH, et al: Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care 22:546-554, 1999
15. Motoyama T, Sano H, Fukuzaki H: Oral magnesium supplementation in patients with essential hypertension. Hypertension 13:227-232, 1989
16. Djurhuus MS, Klitgaard NAH, Pedersen KK, et al: Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes. Metabolism 50:1409-1417, 2001
17. Djurhuus MS, Skøtt P, Hother-Nielsen O, et al: Insulin increases renal magnesium excretion: A possible cause of magnesium depletion in hyperinsulinaemic states. Diabet Med 12:664-669, 1995
18. Djurhuus MS, Skøtt P, Vaag A, et al: Hyperglycaemia enhances renal magnesium excretion in type 1 diabetic patients. Scand J Clin Lab Invest 60:403-410, 2000
19. 3H-ouabain binding site concentration in rat skeletal muscle. Magnesium 6:55-60, 1987
20. Dørup I, Skajaa K, Clausen T, et al: Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. BMJ 296:455-458, 1988
21. Wasada T, Watanabe C, Nakagami T, et al: Adenosine triphosphate-sensitive photassium channels are involved in insulin-mediated glucose transport transport in humans. Metabolism 48:432-436, 1999
22. Hansen L, Echwald SM, Hansen T, et al: Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes 46:508-512, 1997
23. Takimoto K, Levitan ES: Glucocorticoid induction of Kv1.5 k+ channel gene expression in ventricle of rat heart. Circ Res 75:1006-1013, 1994
24. Donovan DS, Solomon CG, Seely EW, et al: Effect of sodium intake on insulin sensitivity. Am J Physiol 264:E730-E734, 1993
25. Sharma AM, Ruland K, Spies KP, et al: Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 9:329-335, 1991
26. Andres R, Baltzan MA, Cader G, et al: Effect of insulin on carbohydrate metabolism and on potassium in the forearm of man. J Clin Invest 41:108-115, 1962
27. DeFronzo RA, Felig P, Ferrannini E, et al. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 238:421-427, 1980
28. 3H]-ouabain binding in identical twins, discordant for type 2 diabetes. J Clin Endocrinol Metab 86:859-866, 2001
29. +-ATPase in diabetes related to insulin, starvation, and training. J Appl Physiol 76:2140-2146, 1994
30. + pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat. Diabetes 36:842-848, 1987
31. Sweeney G. Klip A: Mechanisms and consequences of Na+, K+-pump regulation by insulin and leptin. Cell Mol Biol 47:363-372, 2001
32. Vague P, Dufayet D, Coste T, et al: Association of diabetic neuropathy with Na/K ATPase gene polymorphism. Diabetologia 40:506-511, 1997
33. +)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Horm Metab Res 26:33-38, 1994
34. Henriksen JE, Alford F, Handberg Å. et al: Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest 94:1196-1204, 1994
35. Henriksen JE, Alford F, Ward GM, et al: Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia 40:1439-1448, 1997
36. Djurhuus MS, Klitgaard NAH, Tveskov C, et al: Methodological aspects of measuring human skeletal muscle electrolyte content and ouabain binding capacity. Anal Biochem 260:218-222, 1998
37. Norusis MJ: SPSS/PC+ ver 4.0. Chicago, IL, SPSS, 1990
38. Mathematical Formulae, in Lentner C (ed): Geigy Scientific Tables, vol. 2. Basel, Switzerland, CIBA-GEIGY, 1982
39. Viberti GC: Glucose-induced hyperkalaemia: A hazard for diabetics? Lancet 1:690-691, 1978
40. Feldt-Rasmussen B, Mathiesen ER, Deckert T, et al: Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:610-617, 1987
41. De Chatel R, Weidmann P, Flammer J, et al: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int 12:412-421, 1977
42. Turner HC, Alvarez LJ, Bildin VN, et al: Immunolocalization of Na-K-ATPase, Na-K-Cl and Na-glucose cotransporters in the conjunctival epithelium. Curr Eye Res 21:843-850, 2000
43. Wallner EI, Wada J, Tramonti G, et al: Status of glucose transporters in the mammalian kidney and renal development. Ren Fail 23:301-310, 2001
44. 2. Biochim Biophys Acta 598:100-114, 1980
45. Landin K, Lindgarde F, Saltin B: Skeletal muscle potassium increases after diet and weight reduction in obese subjects with normal and impaired glucose tolerance. Acta Endocrinol Copenh 121:21-26, 1989
46. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
47. Tedde R, Sechi LA, Marigliano A, et al: Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertens 2:163-170, 1989
48. Madsen K, Pedersen PK, Djurhuus MS, et al: Effects of detraining on endurance capacity and metabolic changes during prolonged exhaustive exercise. J Appl Physiol 75:1444-1451, 1993
49. Derave W, Lund S, Holman GD, et al: Contraction-stimulated muscle glucose transport and GLUT-4 surface content are dependent on glycogen content. Am J Physiol 277:E1103-E1110, 1999
50. Ferrannini E, Seghieri G, Muscelli E: Insulin and the renin-angiotensin-aldosterone system: Influence of ACE inhibition. J Cardiovasc Pharmacol 24: S61-S69, 1994 (suppl 3)
51. Preuss HG: Diet, genetics and hypertension. J Am Coll Nutr 16:296-305, 1997
52. Cowley AW: Genetic and nongenetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr 65:587S-593S, 1997
53. Freedman DA, Petitti DB: Salt and blood pressure. Conventional wisdom reconsidered. Eval Rev 25:267-287, 2001
54. Ravn HB, Dørup I: The concentration of sodium, potassium pumps in chronic obstructive lung disease (COLD) patients: The impact of magnesium depletion and steroid treatment. J Intern Med 241:23-29, 1997
55. + pumps in rat skeletal muscle. J Endocrinol 152:49-57, 1997
56. 2-adrenergic stimulation with terbutaline in healthy subjects. Chest 106:1654-1659, 1994
57. + regulation. J Appl Physiol 75:173-180, 1993
58. + pump and muscle contractility. Acta Physiol Scand 152:365-373, 1994